BioVaxys Technology Corp Appoints Christopher Cherry as Chief Financial Officer
Position
Chief Financial Officer
Company
BioVaxys Technology Corp.
EtobicokeBiotechnologyHealth CareTherapeuticsDescription
BioVaxys Technology Corp has appointed Christopher Cherry as its new Chief Financial Officer, citing his extensive experience in similar roles for various public issuers and major accounting firms.
Quick answer
BioVaxys Technology Corp Appoints Christopher Cherry as Chief Financial Officer (April 30, 2024). BioVaxys Technology Corp. is based in Etobicoke, Ontario, Canada.
- Who is the new Chief Financial Officer at BioVaxys Technology Corp?
- BioVaxys Technology Corp. named Christopher Cherry Chief Financial Officer, announced April 30, 2024.
- What did BioVaxys Technology Corp. announce on April 30, 2024?
- BioVaxys Technology Corp has appointed Christopher Cherry as its new Chief Financial Officer, citing his extensive experience in similar roles for various public issuers and major accounting firms.
- What does BioVaxys Technology Corp. do?
- BioVaxys Technology Corp. (CSE:BIOV, OTCQB:BVAXF, FR:5LB), formerly BioVaxys LLC, is a British Columbia-registered clinical-stage biotechnology company dedicated to improving patient lives with novel immunotherapies...
- Where is BioVaxys Technology Corp. based?
- BioVaxys Technology Corp. is based in Etobicoke, Ontario, Canada.
- Which similar companies made leadership changes around the same time?
- Akero Therapeutics (April 30, 2024), Insitro (April 30, 2024), Stoke Therapeutics, Inc. (April 29, 2024) and Evox Therapeutics Ltd (April 29, 2024) also announced leadership changes within 45 days of BioVaxys Technology Corp.
Source: Fundz verified event record.
Other recent leadership changes in Therapeutics and Biotechnology
Executive moves at companies in the same sectors within 45 days, from Fundz verified event records.
- Akero Therapeutics Appoints Scott Gangloff as Chief Technology Officer (April 30, 2024)
- insitro Appoints Emily Fox, Ph.D. as Senior Vice President of AI/Machine Learning (April 30, 2024)
- Stoke Therapeutics Appoints Thomas Leggett as Chief Financial Officer (April 29, 2024)
- Evox Therapeutics Appoints Dr. Per Lundin as Chief Executive Officer (April 29, 2024)
- CureVac N.V. Appoints Thaminda Ramanayake as Chief Business Officer (April 29, 2024)
- Immunome Names Kinney Horn as Chief Business Officer (May 2, 2024)
Who to call at BioVaxys Technology Corp., and when
A new leader at BioVaxys Technology Corp. brings new priorities and often new vendors. The first weeks are when they listen.
- An alert the day BioVaxys Technology Corp. raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at BioVaxys Technology Corp., from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at BioVaxys Technology Corp.. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment BioVaxys Technology Corp. changes its leadership, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
BioVaxys Technology Corp. changed its leadership. Fundz had it the day it was filed, with the decision-maker at the company attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.